Somalogic Mar 30, 2022 SomaLogic Previews New Products, Global Expansion Coming in 2022 Premium Mar 29, 2022 SomaLogic Q4 Revenues Drop 19 Percent but Beat Wall Street Estimate Feb 4, 2022 SomaLogic Initiates 2022 Revenues Guidance of $105M to $110M Jan 12, 2022 JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Jan 6, 2022 Dx IPO Window Widens in 2021 as COVID-19 Testing Provides Jumping Off Point Premium Dec 14, 2021 Canaccord Genuity Initiates Coverage of SomaLogic With Buy Rating Nov 23, 2021 Cowen Initiates Coverage of SomaLogic With Outperform Rating Nov 1, 2021 SomaLogic Collaborating With UH Cleveland Medical Center on Use of SomaSignal Tests Sep 9, 2021 SomaLogic Revenues Almost Triple in First Half of 2021 Sep 1, 2021 SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M Aug 23, 2021 SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent Jun 30, 2021 Even as Testing Demand Started to Wane, COVID-19 Drove IPOs in Dx Space in H1 2021 Premium May 28, 2021 SomaLogic Using Health System Partnerships to Prove Clinical Utility of SomaSignal Tests Premium May 20, 2021 SomaLogic Launches Initiative Aimed at Demonstrating Clinical Value of SomaSignal Tests Mar 29, 2021 SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company Dec 22, 2020 Somalogic Adds $81M to Series A Round, Bringing Total to $214M Dec 8, 2020 Somalogic Using $121M in Funding to Increase Accessibility of SomaScan Platform, Drive Dx Business Nov 25, 2020 Somalogic Closes $121M Series A Funding Oct 13, 2020 SomaLogic, Academic Collaborators Win $1M NSF Grant to Develop Proteomic Screening Assay Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
